Values of IC₅₀ (μg mL⁻¹) of newly developed anticancer agents against MCF-7 and MCF-10A cell lines, as compared to a clinical anticancer drug (5-FU).

Cells	IC50 (μg mL−1) ± SD
	PAHMQ	CoPAHMQ	CuPAHMQ	ZnPAHMQ	5-FU
MCF-7	19.79 ± 0.31	25.79 ± 0.32	11.18 ± 0.39	23.83 ± 0.18	28.34 ± 1.89
MCF-10A	101.29 ± 0.58	149.37 ± 2.1	59.97 ± 0.06	128.84 ± 2.32	41.03 ± 1.89
SI	5.11	5.79	5.63	5.40	1.45